These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 31483058

  • 1. Diagnostic significance of miR-21, miR-141, miR-18a and miR-221 as novel biomarkers in prostate cancer among Egyptian patients.
    Ibrahim NH, Abdellateif MS, Kassem SH, Abd El Salam MA, El Gammal MM.
    Andrologia; 2019 Nov; 51(10):e13384. PubMed ID: 31483058
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.
    Kachakova D, Mitkova A, Popov E, Popov I, Vlahova A, Dikov T, Christova S, Mitev V, Slavov C, Kaneva R.
    DNA Cell Biol; 2015 Mar; 34(3):189-200. PubMed ID: 25521481
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
    Zidan HE, Abdul-Maksoud RS, Elsayed WSH, Desoky EAM.
    IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280
    [Abstract] [Full Text] [Related]

  • 5. Increased Expression of miR-494 in Serum of Patients with Prostate Cancer and its Potential Diagnostic Value.
    Cai B, Peng JH.
    Clin Lab; 2019 Aug 01; 65(8):. PubMed ID: 31414754
    [Abstract] [Full Text] [Related]

  • 6. Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia.
    Jin W, Fei X, Wang X, Chen F, Song Y.
    J Immunol Res; 2020 Aug 01; 2020():5873056. PubMed ID: 32455140
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.
    Leidinger P, Hart M, Backes C, Rheinheimer S, Keck B, Wullich B, Keller A, Meese E.
    Tumour Biol; 2016 Aug 01; 37(8):10177-85. PubMed ID: 26831660
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
    Yang B, Liu Z, Ning H, Zhang K, Pan D, Ding K, Huang W, Kang XL, Wang Y, Chen X.
    Cancer Biomark; 2016 Jul 08; 17(2):223-30. PubMed ID: 27434290
    [Abstract] [Full Text] [Related]

  • 13. A circulating miRNA assay as a first-line test for prostate cancer screening.
    Sharova E, Grassi A, Marcer A, Ruggero K, Pinto F, Bassi P, Zanovello P, Zattoni F, D'Agostino DM, Iafrate M, Ciminale V.
    Br J Cancer; 2016 Jun 14; 114(12):1362-6. PubMed ID: 27228285
    [Abstract] [Full Text] [Related]

  • 14. Plasma Levels of hsa-miR-619-5p and hsa-miR-1184 Differ in Prostatic Benign Hyperplasia and Cancer.
    Knyazev EN, Fomicheva KA, Mikhailenko DS, Nyushko KM, Samatov TR, Alekseev BY, Shkurnikov MY.
    Bull Exp Biol Med; 2016 May 14; 161(1):108-11. PubMed ID: 27265125
    [Abstract] [Full Text] [Related]

  • 15. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
    Kassem NM, Makar WS, Kassem HA, Talima S, Tarek M, Hesham H, El-Desouky MA.
    Asian Pac J Cancer Prev; 2019 Sep 01; 20(9):2749-2755. PubMed ID: 31554373
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased oncogenic microRNA-18a expression in the peripheral blood of patients with prostate cancer: A potential novel non-invasive biomarker.
    Al-Kafaji G, Al-Naieb ZT, Bakhiet M.
    Oncol Lett; 2016 Feb 01; 11(2):1201-1206. PubMed ID: 26893719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.